BeOne Medicines registers Phase 1 trial of BG-T0050 in DLBCL and other B-cell cancersWeekly roundup, 5 itemsazacitidineBeiGene
Trial tests Tislelizumab plus Anlotinib as consolidation therapy in limited-stage SCLCTrial updateBeiGeneSino Biopharmaceutical